Clinical investigation of new medicinal products for the treatment of acute coronary syndrome - Scientific guideline

This guideline replaces 'Points to consider on the clinical investigation of new medicinal products for the treatment of acute coronary syndrome (ACS) without persistent ST segment elevation' (CPMP/EWP/570/98) and 'Points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with ST segment elevation acute myocardial infarction (STEMI)' (CPMP/EWP/967/01).

Keywords: Acute coronary syndrome, STE-ACS, NSTE-ACS

Document history - First version

Topics

How useful was this page?

Add your rating